BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 14383176)

  • 1. [Experience with the thyroid antagonist favistan].
    KLEINDL K
    Med Klin; 1955 Apr; 50(15):672-4. PubMed ID: 14383176
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experiences with 1-methyl-2-mercaptoimidazole (favistan)].
    REIS H
    Munch Med Wochenschr; 1955 Jul; 97(28):903-4. PubMed ID: 13265622
    [No Abstract]   [Full Text] [Related]  

  • 3. [Our experiences with ambulatory therapy of hyperthyroidism with favistan].
    LEVNTAL Z; PUTNIK M; GLIGOROVA N
    Med Glas; 1960 Feb; 14():140-3. PubMed ID: 14416352
    [No Abstract]   [Full Text] [Related]  

  • 4. Experience with methimazole (tapazole) in the treatment of hyperthyroidism; a report of thirty-five cases.
    HALLMAN BL; BONDY PK
    Am J Med; 1951 Dec; 11(6):724-29. PubMed ID: 14902842
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of hyperthyroidism with methimazole].
    PLAMONDON CA; WISWELL JG; ASPER SP
    Laval Med; 1952 Nov; 17(9):1208-19. PubMed ID: 13024096
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of hyperthyroidism with 1-methyl-2-mercaptoimidazole].
    KLEIN E; WIEDENMANN U
    Dtsch Med Wochenschr; 1953 Jun; 78(24):877-8. PubMed ID: 13068021
    [No Abstract]   [Full Text] [Related]  

  • 7. Variations in the response of individuals of different ages to an antithyroid compound (methimazole).
    McGAVACK TH; CHEVALLEY J; PEARSON S
    J Am Geriatr Soc; 1955 Feb; 3(2):96-105. PubMed ID: 14353621
    [No Abstract]   [Full Text] [Related]  

  • 8. Methimazole and carbimazole in hyperthyroidism: a comparison by a double blind technique.
    McGAVACK TH
    Am J Med Sci; 1959 Jul; 238(1):1-12. PubMed ID: 13661169
    [No Abstract]   [Full Text] [Related]  

  • 9. A four-year study of the treatment of hyperthyroidism with methimazole.
    CHEVALLEY J; McGAVACK TH; KENIGSBERG S; PEARSON S
    J Clin Endocrinol Metab; 1954 Aug; 14(8):948-60. PubMed ID: 13183988
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical trial of methimazole in treatment of thyrotoxicosis.
    DAVIDSON LA
    Br Med J; 1953 Dec; 2(4849):1300-3. PubMed ID: 13106417
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of hyperthyroidosis with 1-methyl-2-mercaptiomidazol (mercazole)].
    WURTH K
    Praxis; 1953 Apr; 42(17):331-3. PubMed ID: 13073811
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effectiveness of mercazolyl in thyrotoxicosis].
    BARBA EI
    Probl Endokrinol Gormonoter; 1957; 3(6):99-101. PubMed ID: 13527468
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical experiences with 1-methyl-2-mercaptoimidazole in the treatment of thyrotoxicosis].
    KILPINEN O
    Duodecim; 1952; 68(11):967-71. PubMed ID: 13033768
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of anti-thyroid agents in the treatment of hyperthyroidism].
    Heljić B; Begić A; Begić A; Klancević L
    Med Arh; 2002; 56(2):83-4. PubMed ID: 12014101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agranulocytosis occurring during 1-methyl-2-mercaptoimidazole therapy treated with cortisone and donor bone marrow injection.
    AINSLIE EH; HARLEY HC
    Can Serv Med J; 1955; 11(7):502-8. PubMed ID: 13240627
    [No Abstract]   [Full Text] [Related]  

  • 16. [Intravenous favistan therapy of thyreotoxic crisis].
    HAUSMANN C
    Medizinische; 1958 Jun; 3(24):989-91. PubMed ID: 13565225
    [No Abstract]   [Full Text] [Related]  

  • 17. Exacerbation of hyperthyroidism by methimazole during iodide therapy.
    PROUT TE; ASPER SP
    AMA Arch Intern Med; 1958 Feb; 101(2):364-8. PubMed ID: 13497338
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical experience with 1-methyl-2-mercaptoimidazol in the treatment of hyperthyroidism].
    FISCHER JT; TRAIBEL JA; DI LORENZO J; CORTES R
    Arch Urug Med Cir Espec; 1953; 43(3-4):156-70. PubMed ID: 14350988
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical experience with a new antithyroid drug: 2-carbethoxythio-1-methylglyoxaline.
    BARTELS EC
    J Clin Endocrinol Metab; 1953 Nov; 13(11):1305-11. PubMed ID: 13108951
    [No Abstract]   [Full Text] [Related]  

  • 20. Subclinical hyperthyroidism.
    Parker L
    N Engl J Med; 2002 Jan; 346(1):67-8. PubMed ID: 11778009
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.